John Joseph Berrios
CIK: 0002148420
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GPCR
Structure Therapeutics Inc.
Officer
Discretionary Trading P&L
Holdings
About Berrios John Joseph
Berrios John Joseph (SEC CIK 0002148420) files insider reports with the SEC as Chief Commercial Officer of Structure Therapeutics Inc. (GPCR).
Signal8 holds 2 ownership filings by Berrios John Joseph (1 Form 3, 1 Form 4), filed on Aug 7, 2026. Those filings report 1 transaction, the latest on Aug 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Berrios John Joseph's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Berrios John Joseph
- Aug 6, 2026: Grant or award of GPCR shares (Form 4, code A).
Other insiders filing for Structure Therapeutics Inc. (GPCR)
- Coll Crespo Blas, CHIEF MEDICAL OFFICER
- Lin Xichen, CHIEF SCIENTIFIC OFFICER
- FMR LLC, 10% Owner
- Russell Angus C., Director
- LOVE TED W, Director
- Waldstreicher Joanne, Director